Novel use of platelet-rich plasma to augment curative diabetic foot surgery

Journal of Diabetes Science and Technology

Volumn 4, Issue 5, 2010, Pages 1121-1126

  Scimeca, Christy L ^a   Bharara, Manish ^a   Fisher, Timothy K ^a   Kimbriel, Heather ^a   Armstrong, David G ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetic; Foot surgery; Platelet rich plasma; Wound

Indexed keywords

BIOENGINEERING; CASE REPORT; DIABETIC FOOT; HUMAN; LIMB SALVAGE; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKIN TRANSPLANTATION; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME; WOUND HEALING;

BIOENGINEERING; DIABETIC FOOT; HUMANS; LIMB SALVAGE; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; SKIN TRANSPLANTATION; TREATMENT OUTCOME; WOUND HEALING;

EID: 79952198038     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400510     Document Type: Conference Paper

References (56)

1. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg. 1998;25(3):341-56.
2. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4(4):411-20.
3. Chen C, Schultz GS, Bloch M, Edwards PD, Tebes S, Mast BA. Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds. Wound Repair Regen. 1999;7(6):486-94.
4. Slavkin HC, Bartold PM. Challenges and potential in tissue engineering. Periodontol 2000. 2006;41:9-15.
5. Doucette MM, Fylling C, Knighton DR. Amputation prevention in a high-risk population through a comprehensive wound-healing protocol. Arch Phys Med Rehabil. 1989;70(10):780-5.
6. Knighton DR, Fylling CP, Doucette MM. Wound healing and amputation in a high-risk diabetic population. Wounds. 1989;2:107-14.
7. Knighton DR, Fylling CP, Fiegel VD, Cerra F. Amputation prevention in an independently reviewed at-risk diabetic population using a comprehensive wound care protocol. Am J Surg. 1990;160(5):466-71.
8. Glover JL, Weingarten MS, Buchbinder DS, Poucher RL, Deitrick GA 3rd, Fylling CP. A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care. 1997;10(1):33-8.
9. Fylling CP, McKeown PC. Cost and healing efficacy of treating diabetic foot ulcers in a comprehensive wound management program with growth factor technology. Diabetes. 1990;39:18S.
10. Bentkover JD, Champion AH. Economic evaluation of alternative methods of treatment for diabetic foot ulcer patients: cost-effectiveness of platelet releasate and wound care clinics. Wounds. 1993;5:207-15.
11. Armstrong DG, Lavery LA, Bushman TR. Peak foot pressures influence healing time of diabetic ulcers treated with total contact casts. J Rehabil Res Dev. 1998;35(1):1-5.
12. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158(2):157-62.
13. Armstrong DG, Lavery LA, Vazquez JR, Short B, Kimbriel HR, Nixon BP, Boulton AJ. Clinical efficacy of the first metatarsophalangeal joint arthroplasty as a curative procedure for hallux interphalangeal joint wounds in patients with diabetes. Diabetes Care. 2003,26(12):3284-7.
14. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-8.
15. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4-15.
16. Martinowitz U, Spotnitz WD. Fibrin tissue adhesives. Thromb Haemost. 1997;78(1):661-6.
17. Lin PH, Hirko MK, von Fraunhofer JA, Greisler HP. Wound healing and inflammatory response to biomaterials. In: Chu CC, von Fraunhofer JA, Greisler HP, eds. Wound closure biomaterials and devices. Boca Raton: CRC Press; 1997, 7-24.
18. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995;13(5):655-63.
19. Kevy SV, Jacobson MS. Preparation of growth factor enriched autologous platelet gel. Presented at the 27th Annual Meeting of the Society for Biomaterials, St. Paul, MN, April 26, 2001.
20. Spencer EM, Tokunaga A, Hunt TK. Insulin-like growth factor binding protein-3 is present in the alpha-granules of platelets. Endocrinology. 1993;132(3):996-1001.
21. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev. 1993;7(1):52-62.
22. Gibble JW, Ness PM. Fibrin glue: the perfect operative sealant? Transfusion. 1990;30(8):741-7.
23. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4-15.
24. Ogino Y, Ayukawa Y, Tsukiyama Y, Koyano K. The effect of platelet-rich plasma on the cellular response of rat bone marrow cells in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(3):302-7.
25. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638-46.
26. Doucette MM, Fylling C, Knighton DR. Amputation prevention in a high-risk population through a comprehensive wound-healing protocol. Arch Phys Med Rehabil. 1989;70(10):780-5.
27. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502-8.
28. Rubin R, Baserga R. Biology of disease: insulin-like growth factor receptor, its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest. 1995;73(3):311-31.
29. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822-7.
30. d'Hemecourt PA, Smiell JM, Karim MR. Sodium carboxymethylcellulose aqueous-based gel versus becaplermin gel in patients with nonhealing, lower extremity diabetic ulcers. Wounds. 1998;10(3):69- 75.
31. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 1999;7(5):335-46.
32. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986;204(3):322-30.
33. Deuel TF, Kawahara RS, Mustoe TA, Pierce AF. Growth factors and wound healing: platelet-derived growth factor as a model cytokine. Annu Rev Med. 1991;42:567-84.
34. Ross R. Platelet-derived growth factor. Lancet. 1989;1(8648):1179-82.
35. Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care. 2005;28(2):461-71.
36. Hosgood G. Wound healing. The role of platelet-derived growth factor and transforming growth factor beta. Vet Surg. 1993;22(6):490-5.
37. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45(4):319-26.
38. Pfeilschifter J, Oechsner M, Naumann A, Gronwald RG, Minne HW, Ziegler R. Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology. 1990;127(1):69-75.
39. Hosgood G. Wound healing. The role of platelet-derived growth factor and transforming growth factor beta. Vet Surg. 1993;22(6):490-5.
40. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg. 2003;90(2):133-46.
41. Wu L, Xia YP, Roth SI, Gruskin E, Mustoe TA. Transforming growth factor-b1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: importance of oxygen and age. Am J Pathol. 1999;154:301-9.
42. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13(1):9-22.
43. Brauchle M, Funk JO, Kind P, Werner S. Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem. 1996;271(36):21793-7.
44. Diegelmann RF, Evans MC. Wound healing: an overview of acute fibrotic and delayed healing. Front Biosci. 2004;9-283-9.
45. Vaisman N, Gospodarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem. 1990;265(32):19461-6.
46. Plouët J, Moukadiri, H. Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J Biol Chem. 1990;265(36):22071-4.
47. Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg. 1999;134(2):200-5.
48. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502-8.
49. Knighton DR, Phillips GD, Fiegel VD. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor. J Trauma. 1990;30(12 Suppl):S134-44.
50. Ganio C, Tenewitz FE, Wilson R, Moyles BG. The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg. 1993;32(3):263-8.
51. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion. 2004;44(7):1013-8.
52. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736-43.
53. Henderson JL, Cupp CL, Ross EV, Shick PC, Keefe MA, Wester DC, Hannon T, McConnell D. The effects of autologous platelet gel on wound healing. Ear Nose Throat J. 2003;82(8):598-602.
54. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Moroni M, Carabelli A. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004;30(2):145-51.
55. Everts PA, Devilee RJ, Brown Mahoney C, Eeftinck-Schattenkerk M, Box HA, Knape JT, van Zundert A. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand. 2006;50(5):593-9.
56. Hom DB, Linzie BM, Huang TC. The healing effects of autologous platelet gel on acute human skin wounds. Arch Facial Plast Surg. 2007;9(3):174-83.